CClinicalTrials.gg
CompletedNCT03754699PELOPSUpdated Jan 29, 2026

Preoperative Education for Less Outpatient Pain After Surgery (PELOPS)

An interventional study of Educational intervention and Standard information in Outpatient Orthopedic Surgery, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-29.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
412
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In 2015, more than 50% of surgical procedures were performed in outpatient settings. Successful pain management after outpatient surgery is crucial, and requires a perfect cooperation between caregivers and patients, with clear information on the analgesics use at home. Different strategies to control postoperative pain were adopted by hospitals performing outpatient surgery. However, up to half of patients receive little or no information about the treatment of postoperative pain, and at least one third of them are not able to follow postoperative analgesia instructions. There is a clear unmet need in pain treatment during first 48-72 hours after discharge, with important number of emergency calls and readmissions. The most common causes of rescue calls after outpatient surgery are uncontrolled pain and questions about medications or post-operative care.

Structured education interventions using psychological techniques to enhance engagement and behavior were found to be beneficial for better acute pain management in outpatient settings after orthopedic surgery.

We hypothesize that an educational intervention based on the rational perception of postoperative pain and discomfort, and the proper use of analgesics would improve the quality of pain management at home and reduce analgesics-related side effects.

Principal objective of this study is to evaluate the impact of a preoperative educational intervention on effectiveness of postoperative pain self-management in outpatient settings compared to the current practice.

Secondary objectives are to evaluate the prevalence of analgesics use and the incidence of severe pain episodes, as well as side effects. The occurrence of neurological pain, quality of sleep, and patient's comfort will be evaluated at 30th day after surgery.

02

Conditions studied

  • Outpatient Orthopedic Surgery

Browse trials for

Keywords

  • Pain
  • Surgery
  • Preoperative Education
  • Outpatient
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's enrollment of 412 is above the median of 70 across 1,904 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults (age ≥ 18 years);
  • Patients scheduled for outpatient orthopedic surgery
  • ASA (American Society of Anesthesiology) I to III;
  • Patients admitted for an outpatient intervention resulting in moderate to severe pain: eg: arthroscopy of the knee or shoulder, cruciate ligaments, shoulder block, medial patellofemoral ligament plasty (not exhaustive)

Exclusion criteria

Exclusion Criteria:

  • Pregnant or lactating women
  • Patients with contraindications to paracetamol and/or second-level analgesic and/or NSAIDs (hepatocellular insufficiency, respiratory insufficiency, substituted or unsubstituted drug addicts, allergy to one of the drugs, history of bleeding or digestive perforation during previous NSAID treatment, history of gastroduodenal ulcer, renal failure with clearance \<50mL / min, severe heart failure)
  • Patients with preoperative chronic pain (outside operative site, known or detected by DN4)
  • Patients admitted for an outpatient arthroplasty (excluded because they are subjected of a specific preoperative preparation)
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care, persons admitted to a health or social establishment for other purposes than research
  • Patient with a poor understanding of French
  • Patient refusing to participate to the study
  • Patient not affiliated to a social security regimen
  • Patient participating in other interventional research except a routine care research (former regulation) and/or research with no interference with the primary endpoint analysis as determined by the investigator.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
412 participants (actual)

Study arms

  • Experimental
    Patients with a therapeutic educational intervention

    Arm 1 : Interventional group: A therapeutic educational intervention is performed following pre-anesthesia assessment

    Behavioral: Educational intervention

  • Active comparator
    Patients without therapeutic educational intervention

    Arm 2 : Control group: standard information on pain is performed following pre anesthesia assessment

    Behavioral: Standard information

Interventions

  • BehavioralEducational intervention

    During the usual pre-anesthesia assessment (performed between D-30 and D0 of the intervention), the anesthesiologist will deliver to the intervention group patient oral and visual information on: * the numerical scale of pain ranging from 0 to 10 with examples of perceptions corresponding to each level of the scale (calibration) * nature of postoperative pain (inflammatory character, dynamic over time) * average pain level incurred by the intervention * the difference between anti-inflammatory and opioid analgesics * principles of systematic treatment and pain anticipation * principles of overdose and side effects prevention This information is standardized and delivered orally, accompanied by a visual support (patient diary), which will be given to the patient upon discharge from the hospital

  • BehavioralStandard information

    Standard information on pain For patients in the control group the standardized information is based on the SG/DGM/DSS 1/41-2010 scheme of the AFSSAPS-CFETD repository.

06

What researchers measure

Primary outcomes

  1. Time-weighted sum of Pain Relief - Total Pain Relief (TOTPAR) during 5 postoperative days

    TOTPAR is a global score based on relief of pain. A numerical scale has at its left end the words "no relief = 0" and at its right end "complete relief = 100%". The pain relief score is calculated using the area under the curve for a defined period of time. TOTPAR is also expressed as a percentage of the maximum TOTPAR that would be achieved by treatment that would provide complete relief during the observation period. In order to measure this area under the curve, at least 3 measurements per day will have to be reported in the patient diary.

    Time frame: Day 5

Secondary outcomes

  1. Time-weighted sum of Pain Relief - Total Pain Relief (TOTPAR)

    TOTPAR is a global score based on relief of pain. A numerical scale has at its left end the words "no relief = 0" and at its right end "complete relief = 100%". The pain relief score is calculated using the area under the curve for a defined period of time. TOTPAR is also expressed as a percentage of the maximum TOTPAR that would be achieved by treatment that would provide complete relief during the observation period. In order to measure this area under the curve, at least 3 measurements per day will have to be reported in the patient diary.

    Time frame: At Day 10, Day 20 and Day 30 with the initial point at Day 5

  2. Type, number and doses of prescribed analgesics

    Patient will report drug intake on a patient diary

    Time frame: At Day 0, Day 1, Day 2, Day 3, Day 4, Day 5, Day 10, Day 20 and Day 30.

  3. Incidence of severe pain (≥ 7 out of 10).

    The patient diary will provide a continuous assessment at home of the pain intensity

    Time frame: From day 0 to the end of stidy (Day 30)

  4. Incidence of side effects (nausea / vomiting / gastralgia / dizziness / concentration disorder / somnolence / constipation, other).

    Side effects will be collected on the patient diary

    Time frame: From day 0 to the end of stidy (Day 30)

  5. Prevalence of neuropathic pain assessed by using the DN4 scale.

    Patient will complete the DN4 questionnaires the day of the pre-anesthetic consultation and at Day 30 on the patient diary.

    Time frame: At Day 30

  6. Sleep quality at day 0 and day 30 by the Pittsburgh Sleep Quality Index

    Patient will complete the PSQI questionnaires the day of the pre-anesthetic consultation and at Day 30 on the patient diary.

    Time frame: At Day 0 and Day 30

  7. Comfort and experience of the patient evaluated by the International Pain Outcome questionnaire.

    Patient will complete the International Pain Outcome questionnaire at day 30, on the patient diary

    Time frame: At Day 30

07

Study locations

1 site
  • Hospices Civils de Lyon - Hopital de la Croix Rousse - Anaesthesia Reanimation unit
    Lyon, 69004, France
08

References and documents

Publications

  • Dziadzko M, Bouteleux A, Minjard R, Harich J, Joubert F, Pradat P, Pantel S, Aubrun F. Preoperative Education for Less Outpatient Pain after Surgery (PELOPS trial) in orthopedic patients-study protocol for a randomized controlled trial. Trials. 2022 May 21;23(1):422. doi: 10.1186/s13063-022-06387-6. PubMed 35598000 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03754699
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Nov 27, 2018
Start date
Jan 22, 2019
Primary completion
Sep 15, 2025
Completion
Sep 15, 2025
Last update
Jan 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion